960 results on '"Hourihane, Jonathan"'
Search Results
2. Time to ACT-UP: Update on precautionary allergen labelling (PAL)
3. ASQ-3 and BSID-III’s concurrent validity and predictive ability of cognitive outcome at 5 years
4. Dietary Advancement Therapy Using Milk and Egg Ladders Among Children With a History of Anaphylaxis
5. Preparing Patients for Oral Immunotherapy (PPOINT): International Delphi consensus for procedural preparation and consent
6. Early skin inflammatory biomarker is predictive of development and persistence of atopic dermatitis in infants
7. Precautionary Allergen Labeling: What Advice Is Available for Health Care Professionals, Allergists, and Allergic Consumers?
8. Participant characteristics and safety outcomes of peanut oral immunotherapy in the RAMSES and ARC011 trials
9. Study protocol: assessing SleeP IN infants with early-onset atopic Dermatitis by Longitudinal Evaluation (The SPINDLE study)
10. Peanut Can Be Used as a Reference Allergen for Hazard Characterization in Food Allergen Risk Management: A Rapid Evidence Assessment and Meta-Analysis
11. Managing Food Allergy When the Patient Is Not Highly Allergic
12. The Positive and Negative Affect Schedule — Food Allergy (PANAS-FA): Adaptation and psychometric properties
13. The impact of an evidence‐based myth‐busting information intervention on maternal food allergy‐related quality of life, anxiety and self‐efficacy
14. The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach
15. Development of the Food Allergy Anxiety Scale in an Adult Population: Psychometric Parameters and Convergent Validity
16. Continuous and Daily Oral Immunotherapy for Peanut Allergy: Results from a 2-Year Open-Label Follow-On Study
17. Improvements in Quality of Life in Children Following Epicutaneous Immunotherapy (EPIT) for Peanut Allergy in the PEPITES and PEOPLE Studies
18. Association between gut microbiota development and allergy in infants born during pandemic‐related social distancing restrictions.
19. A retrospective comparison of IgE‐mediated cow's milk protein allergy management strategies in pediatric cohorts.
20. Risk Factors and Characteristics of Biphasic Anaphylaxis
21. Managing Food Allergy in Schools During the COVID-19 Pandemic
22. In vivo Raman spectroscopy discriminates between FLG loss-of-function carriers vs wild-type in day 1-4 neonates
23. The Role of Shared Decision Making in Pediatric Food Allergy Management
24. O02 Assessing SleeP in INfants with moderate-severe atopic Dermatitis by Longitudinal Evaluation (The SPINDLE study)
25. Deriving individual threshold doses from clinical food challenge data for population risk assessment of food allergens
26. Safety and effectiveness of a milk ladder for managing children with IgE‐mediated milk allergy
27. EAACI guidelines on the diagnosis of IgE‐mediated food allergy
28. Dietary Advancement Therapy using milk and egg ladders among children with a history of anaphylaxis
29. Atopic outcomes at 2 years in the CORAL cohort, born in COVID‐19 lockdown
30. We should abandon the Brighton Collaboration criteria for vaccine-associated anaphylaxis
31. Epinephrine in Severe Allergic Reactions: The European Anaphylaxis Register
32. Preliminary Development of the Food Allergy Coping and Emotions Questionnaires for Children, Adolescents, and Young People: Qualitative Analysis of Data on IgE-Mediated Food Allergy from Five Countries
33. The relationship between IGF-I and -II concentrations and body composition at birth and over the first 2 months
34. A comprehensive questionnaire for the assessment of health-related quality of life in coeliac disease (CDQL)
35. Infants born during the COVID-19 pandemic have less interest in masked faces than unmasked faces
36. Increased rates of invasive bacterial disease in late 2022
37. Primary care as a setting for introducing milk using the milk ladder in children with IgE‐mediated cow's milk protein allergy
38. Early emollient bathing is associated with subsequent atopic dermatitis in an unselected birth cohort study
39. No evidence of isotretinoin sensitization in peanut-allergic children: a cross-sectional study
40. Developmental and behavioural outcomes at 2 years in babies born during the COVID-19 pandemic: communication concerns in a pandemic birth cohort
41. An Examination of the Food Allergy Quality of Life Questionnaire Performance in a Countrywide American Sample of Children: Cross-Cultural Differences in Age and Impact in the United States and Europe
42. Skin microbiome before development of atopic dermatitis: Early colonization with commensal staphylococci at 2 months is associated with a lower risk of atopic dermatitis at 1 year
43. Retraction Note to: Partially hydrolysed, prebiotic supplemented whey formula for the prevention of allergic manifestations in high risk infants: a multicentre double-blind randomised controlled trial
44. Variation in iodine food composition data has a major impact on estimates of iodine intake in young children
45. Low vitamin D deficiency in Irish toddlers despite northerly latitude and a high prevalence of inadequate intakes
46. Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with Peanut Allergy
47. Gut microbiome predicts atopic diseases in an infant cohort with reduced bacterial exposure due to social distancing
48. Cow's milk and hen's egg anaphylaxis: A comprehensive data analysis from the European Anaphylaxis Registry
49. Early initiation of short-term emollient use for the prevention of atopic dermatitis in high-risk infants-The STOP-AD randomised controlled trial
50. EAACI guidelines on the diagnosis of IgE-mediated food allergy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.